معرفی
Kimberly Brien serves as an Associate Professor of Chemistry at Rhodes College in Memphis, Tennessee, where she leads an active research laboratory focused on organometallic chemistry applications in anti-cancer drug development and catalysis of organic reactions.
Her academic credentials include:
- Post-doctoral Researcher: Hope College
- Ph.D.: Texas Christian University
- M.S.: Baylor University
- B.S.: Texas Lutheran University
Dr. Brien's research program centers on two primary initiatives: synthesizing main-group derivatives of suberoylanilide hydroxamic acid (SAHA) to develop selective histone deacetylase (HDAC) inhibitors with reduced off-target effects for improved cancer therapy, and investigating metal complexes of 2,6-bis-hydrazinopyridine (BHP) derivatives to create novel tridentate ligands for catalytic applications. Her work bridges synthetic organic chemistry, inorganic chemistry, and medicinal pharmacology through innovative molecular design.
Analysis of her 2005-2013 publications reveals consistent interdisciplinary contributions spanning cancer drug development (HDAC inhibitors, chalcone analogs, DNA-binding polyamides) and inorganic materials science (bismuth complexes, ligand characterization). Key trends include structural optimization for biological activity, X-ray crystallographic validation of novel compounds, and exploration of main-group metal applications in medicinal chemistry.
No scientific awards were documented in the source materials.
Dr. Brien mentors undergraduate researchers in her laboratory, though specific student names are unlisted. Grant funding details were not provided in the available text.
The Brien Research Laboratory operates within Berthold S. Kennedy Hall at Rhodes College, conducting collaborative work on drug synthesis, biological activity assays, and structural analysis of organometallic compounds.
